# Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy

> **NCT00480857** · PHASE2 · TERMINATED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 19 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Docetaxel (Taxotere)

## Key facts

- **NCT ID:** NCT00480857
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** 2013-08
- **Final completion:** 2014-07
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Lack of funding.
- **Last updated:** 2017-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00480857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00480857, "Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00480857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*